Magellan Rx Specialty Drug Program

Posted on October 28, 2015

Effective 1/4/16, Health New England will be implementing a change in the way we manage certain specialty drugs that fall under the medical benefit. We will now be requiring prior authorization for the following drug areas: Oncology, Oncology Support (antiemetic, neutropenia) Anemia Hereditary Angioedema Inflammatory Conditions Immunodeficiency (IVIG) HNE also will be implementing a post […]